Screening Cardiovascular Patients for Aortic aNeurysms (SCAN) (SCAN)

January 5, 2017 updated by: Univ.-Prof. Dr. med. Hans-Henning Eckstein, Technical University of Munich
The aim of the cohort study SCAN (Screening Cardiovascular patients for Aortic aNeurysms) is to establish a screening programm for patients with a high risk for an AAA. Aortic aneurysms in these patients should be identified at an early stage and thereby AAA-associated mortality be decreased.

Study Overview

Status

Unknown

Detailed Description

A recently published meta-analysis showed a higher prevalence of aortic aneurysm (AAA) in men requiring treatment of coronary heart disaese compared to standard population. In women, however, the prevalence was not increased. Thus, the SCAN project addresses male patients who underwent coronary artery intervention in order to screen them for the presence of an AAA using duplex sonography.

The SCAN project involves the following elements:

  1. Informing the patient with cardiovascular risk factors about the clinical picture of AAA
  2. An ultrasound scan of the abdominal aorta in patients with an increased risk for AAA
  3. Acquisition of patient data followed by a correlation analysis for the parameters presence of AAA and cardiovascular diseases

The cohort study is part of the SCAN project which is also conducted in an similar way by Catharina Ziekenhuis Eindhoven ClinicalTrials.gov Identifier:NCT01643317.

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bayern
      • Munich, Bayern, Germany, 81675
        • Recruiting
        • Klinikum rechts der Isar, Klinik und Poliklinik für Vaskuläre und Endovaskuläre Chirurgie
        • Contact:
        • Contact:
        • Principal Investigator:
          • Hans-Henning Eckstein, Prof.Dr.med.
        • Sub-Investigator:
          • Benedikt Reutersberg
      • München, Bayern, Germany, 81675
        • Recruiting
        • I. Medizinischen Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München
        • Contact:
        • Principal Investigator:
          • Karl-Ludwig Laugwitz, Univ.-Prof.Dr.med.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Men with coronary artery intervention (PTCA/stenting) and at least 1 risk factor for AAA (hypertension, hyperlipidaemia, hyperuricemia, nicotine abuse,positive family history.

Description

Inclusion Criteria:

  • men with coronary artery intervention (PTCA/stenting)
  • at least 1 risk factor for AAA (hypertension, hyperlipidaemia, hyperuricemia, nicotine abuse,positive family history)

Exclusion Criteria:

  • life expectancy less than 1 year
  • inability to follow the instructions of the investigator (dementia, lack of time, insufficient understanding of the language)
  • insufficient compliance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of AAA
Time Frame: 1 year
Ultrasound screen for the presence of an AAA
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of AAA in the cohort requiring treatment
Time Frame: 1 year
Measuring the AAA diameter
1 year
Correlation of risk factors for AAA with risk factors for coronary artery disease
Time Frame: 1 year
Therefore the cardiovascular risk factors ( diabetes, hypertension, hyperlipidaemia, hyperuricemia, nicotine abuse, positive family history, obesity) will be requested.
1 year
Distribution of risk factors
Time Frame: 1 year
Distribution of cardiovascular risk factors (diabetes, hypertension, hyperlipidaemia, hyperuricemia, nicotine abuse, positive family history, obesity) between patients with an without an AAA
1 year
Correlation of the number of treated vessels and AAA
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hans-Henning Eckstein, Univ.-Prof.Dr.med., Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar der Technische Universität München
  • Principal Investigator: Karl-Ludwig Laugwitz, Univ.-Prof.Dr.med., I. Medizinischen Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Anticipated)

December 1, 2017

Study Completion (Anticipated)

April 1, 2018

Study Registration Dates

First Submitted

June 12, 2014

First Submitted That Met QC Criteria

June 30, 2014

First Posted (Estimate)

July 2, 2014

Study Record Updates

Last Update Posted (Estimate)

January 6, 2017

Last Update Submitted That Met QC Criteria

January 5, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Aortic Aneurysm

3
Subscribe